Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • US

    Tag: US

    You Searched For "US"
    Regeneron partners with US to develop treatment for coronavirus

    Regeneron partners with US to develop treatment for coronavirus

    Medical Dialogues Bureau7 Feb 2020 9:30 AM IST
    US: The United States is working with a pharmaceutical company to develop a treatment for the 2019 Novel Coronavirus, using a class of drug that has...
    Novo Nordisks Ozempic® gets USFDA for CV risk reduction in people with type 2 diabetes and established CVD

    Novo Nordisk's Ozempic® gets USFDA for CV risk reduction in people with type 2 diabetes and established CVD

    Medical Dialogues Bureau18 Jan 2020 10:36 AM IST
    Denmark: Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved a label expansion based on a supplemental New...
    3 Indian-origin healthcare startup executives charged in USD 1 billion fraud in US

    3 Indian-origin healthcare startup executives charged in USD 1 billion fraud in US

    Farhat Nasim27 Nov 2019 11:59 AM IST
    The co-founders of Outcome Health Rishi Shah, 33, and Shradha Aggarwal, 34, and former executive Ashik Desai, 26, are among six people accused of...
    Bayer Roundup suits increase to 42700

    Bayer Roundup suits increase to 42700

    Medical Dialogues Bureau1 Nov 2019 9:00 AM IST
    A court-appointed mediator between Bayer and US plaintiffs in August denied reports the company had offered an $8 billion settlement to get the cases...
    FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

    FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

    Farhat Nasim14 Oct 2019 1:13 PM IST
    New Delhi: Through a release, drug major, Sun Pharmaceutical Industries Ltd. (Sun Pharma) today announced that one of its wholly-owned subsidiaries...
    SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA

    SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA

    Farhat Nasim5 Oct 2019 12:00 PM IST
    Orphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of patients with neonatal...
    Cadila Healthcare to sell right of cholesterol-lowering drug Zypitamag for Rs 49 crore

    Cadila Healthcare to sell right of cholesterol-lowering drug Zypitamag for Rs 49 crore

    Farhat Nasim1 Oct 2019 2:13 PM IST
    The company has entered into an asset purchase agreement to sell its right, title and interest in Zypitamag, along with applicable registrations and...
    Strides Pharma gets USFDA nod for generic version of Vesicare Tablets to treat overactive bladder

    Strides Pharma gets USFDA nod for generic version of Vesicare Tablets to treat overactive bladder

    Medical Dialogues Bureau28 Sept 2019 2:38 PM IST
    "Solifenacin Succinate Tablet is a generic version of Vesicare Tablets, 5 mg and 10 mg, of Astellas Pharma US, Inc, " Strides Pharma said.Bangalore:...
    Cipla launches skin treatment Daptomycin Injection in US

    Cipla launches skin treatment Daptomycin Injection in US

    Medical Dialogues Bureau27 Sept 2019 1:53 PM IST
    Drug firm Cipla on Wednesday said it has launched Daptomycin Injection, used for treating complicated skin infections, in the US market. Daptomycin...
    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Medical Dialogues Bureau23 Sept 2019 10:00 AM IST
    Ranitidine is an Over-The-Counter (OTC) and prescription drug which decreases the amount of acid created by the stomach.Hyderabad: Dr Reddy's...
    GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction

    GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction

    Farhat Nasim19 Sept 2019 9:30 AM IST
    Johnson & Johnson (JnJ), GSK Plc's developmental partner, sell the over-the-counter nicotine oral spray in 45 countries, excluding the United...
    Cigna new plan to cover expensive gene therapies including Novartis Zolgensma, Luxturna

    Cigna new plan to cover expensive gene therapies including Novartis Zolgensma, Luxturna

    Medical Dialogues Bureau8 Sept 2019 9:00 AM IST
    The first two gene therapies to be included in Cigna Corp's program are blindness therapy, Luxturna, and the most expensive drug in the world...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok